Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tadalafil,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved
Sponsor : Mangoceuticals
Deal Size : Undisclosed
Deal Type : Agreement
Mangoceuticals' MangoRx Mexico Signs Agreement for Development Of ED Products
Details : Emifarma will be responsible for initial development & testing of the Company’s Mango ED products a combination of Tadalafil, Oxytocin, and L-Arginine intended for Mexican and Latin American markets.
Brand Name : Mango ED
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 12, 2024
Lead Product(s) : Tadalafil,Oxytocin,L-Arginine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved
Sponsor : Mangoceuticals
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?